Abstract
Detection of DCIS and reduced invasive interval cancers
Highlights
Taiho in 2009, and received study medication for PI-initiated trials and honorarium for scientific presentations from TTY, Taiwan, in the past
When breast screening began in the UK, such was the uncertainty concerning the benefits and harms of detecting ductal carcinoma in situ (DCIS) that national guidelines specified an upper limit as well as a lower limit for detection by individual screening centres
This was only changed when an association was shown between DCIS detection and small invasive cancer detection in the National Health Service Breast Screening Programme.[1]
Summary
Taiho in 2009, and received study medication for PI-initiated trials and honorarium for scientific presentations from TTY, Taiwan, in the past. 6 Chen JS, Chao Y, Hsieh RK, et al A phase II and pharmacokinetic study of Department of Internal Medicine, Kaohsiung Medical University first-line S-1 for advanced gastric cancer in Taiwan.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
